Combined DMT–harmine formulation reduces negative self-referential emotions during social self-evaluation: a randomized placebo-controlled trial in healthy volunteers

A new study examined whether a pharmaceutical formulation inspired by ayahuasca could reduce feelings of shame and embarrassment during socially evaluative situations

A new study examined whether a pharmaceutical formulation inspired by ayahuasca could reduce feelings of shame and embarrassment during socially evaluative situations

This was a Randomised, double-blind, placebo-controlled, crossover trial. 36 healthy men were recruited; 28 completed the full protocol and were included in the primary analyses.

Interventions:

  • Harmine (100 mg buccal) + DMT (100 mg intranasal, given as repeated 10 mg doses)

  • Harmine alone (100 mg)

  • Placebo

  • Each participant received all three interventions on separate study days

Key findings

Reduced embarrassment about oneself - Compared with placebo, the harmine + DMT combination significantly reduced embarrassment when participants listened to recordings of their own singing.

Reduced shame - The combined treatment significantly lowered:

  • overall shame scores

  • the emotional component of shame

Increased positive emotional responses

During self-listening, participants receiving harmine + DMT reported:

  • less unpleasantness

  • greater pleasantness

than under placebo, suggesting an acute shift towards more positive emotional processing of self-relevant experiences

Harmine alone showed little effect - Harmine without DMT did not significantly reduce embarrassment or shame.

The study provides early experimental evidence that an ayahuasca-inspired harmine + DMT formulation can acutely reduce embarrassment and emotional shame during socially evaluative situations in healthy men. Harmine alone produced no significant benefit. While the findings support further investigation into psychedelic-assisted treatments targeting excessive self-criticism and shame, they should not be interpreted as evidence of efficacy for psychiatric disorders until confirmed in larger clinical trials.

Abstract

Rationale and objectives

Negative self-referential emotions such as embarrassment and shame play a key role in the psychopathology of psychiatric disorders but are often insufficiently addressed by standard treatments. Psychedelics such as ayahuasca – an Amazonian plant decoction containing the psychedelic N,N-dimethyltryptamine (DMT) and harmala alkaloids, have been proposed to positively modulate self-referential processing. The aim of this study was to investigate the effects of an ayahuasca-inspired harmine+DMT formulation and harmine on embarrassment and shame.

Methods

In this randomized, double-blind, placebo-controlled crossover trial (N = 28 healthy males), the effects of combined 100mg harmine and 100mg DMT (HAR/DMT), harmine alone (HAR), against placebo (PLA) on self-referential processing was investigated using a karaoke paradigm, where participants listened to recordings of their own singing (Self = S) and control vocal tracks (other bad = OB; other good = OG) and rated emotional responses. Acute emotions were assessed with visual analogue scales (items: pleasant, unpleasant, embarrassing, funny, and objective quality) and the Experiential Shame Scale (ESS).

Results

HAR/DMT compared to placebo significantly reduced embarrassment in the Self condition (EMM=-16.83, p=.001), but not in the two other conditions (OB: EMM=-4.38, p=.628; OG: EMM= 2.14, p=.894). HAR/DMT–HAR or HAR–PLA contrasts for embarrassment were not significant for any condition. HAR/DMT compared to placebo reduced ESS global score (F(df)= 4.26(2, 54); p=.019) and ESS emotional subscale (F(df)=5.11(2, 54); p=.009), while harmine alone showed no significant effects.

Conclusions

These findings suggest that HAR/DMT acutely modulates negative self-referential emotions and may, thus, offer a promising therapeutic approach, which should be further investigated in clinical populations.

Aicher, H.D., Dornbierer, J., Caflisch, L. et al. Combined DMT–harmine formulation reduces negative self-referential emotions during social self-evaluation: a randomized placebo-controlled trial in healthy volunteers. Psychopharmacology (2026). Read Paper


For more psychedelic news
and research, visit the psychedelic health professional network homepage.

Previous
Previous

Mescaline Alters Cerebellar Function, Global Connectivity, and Frequency-Selective Acoustic Gating: A BOLD fMRI Study in Awake Rats

Next
Next

A Single Dose of a Psychedelic Drug Repairs Prefrontal Cortex Synaptic Physiology in a Mouse Model of Prenatal Alcohol Exposure